home / stock / ate:cc / ate:cc quote
Last: | $0.58 |
---|---|
Change Percent: | -3.33% |
Open: | $0.6 |
Close: | $0.60 |
High: | $0.6 |
Low: | $0.58 |
Volume: | 9,300 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.58 | $0.6 | $0.6 | $0.6 | $0.58 | 9,300 | 08-02-2022 |
$0.71 | $0.7 | $0.71 | $0.72 | $0.7 | 42,836 | 05-06-2022 |
$0.71 | $0.7 | $0.71 | $0.72 | $0.7 | 59,159 | 05-05-2022 |
$0.72 | $0.69 | $0.72 | $0.73 | $0.69 | 55,511 | 05-04-2022 |
$0.72 | $0.7 | $0.72 | $0.75 | $0.68 | 51,358 | 05-03-2022 |
$0.71 | $0.67 | $0.71 | $0.71 | $0.66 | 111,130 | 05-02-2022 |
$0.67 | $0.66 | $0.67 | $0.67 | $0.66 | 22,600 | 04-29-2022 |
$0.67 | $0.68 | $0.67 | $0.69 | $0.67 | 93,610 | 04-28-2022 |
$0.68 | $0.69 | $0.68 | $0.69 | $0.67 | 65,484 | 04-27-2022 |
$0.68 | $0.71 | $0.68 | $0.71 | $0.67 | 39,764 | 04-26-2022 |
$0.72 | $0.7 | $0.72 | $0.72 | $0.7 | 48,988 | 04-25-2022 |
$0.72 | $0.76 | $0.72 | $0.76 | $0.7 | 109,449 | 04-22-2022 |
$0.76 | $0.77 | $0.76 | $0.78 | $0.74 | 29,450 | 04-21-2022 |
$0.78 | $0.76 | $0.78 | $0.78 | $0.75 | 28,398 | 04-20-2022 |
$0.77 | $0.78 | $0.77 | $0.79 | $0.76 | 58,470 | 04-19-2022 |
$0.78 | $0.74 | $0.78 | $0.82 | $0.74 | 88,965 | 04-18-2022 |
$0.74 | $0.73 | $0.74 | $0.75 | $0.72 | 20,459 | 04-15-2022 |
$0.74 | $0.73 | $0.74 | $0.75 | $0.72 | 20,459 | 04-14-2022 |
$0.74 | $0.74 | $0.74 | $0.76 | $0.74 | 23,573 | 04-13-2022 |
$0.75 | $0.75 | $0.75 | $0.76 | $0.74 | 25,693 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Antibe Therapeutics Inc. Company Name:
ATE:CC Stock Symbol:
TSXC Market:
Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE) announced that the Company’s request for an extension of its previously announced stay of proceedings under the Companies’ Creditors Arrangement Act (the “ CCAA ”...
Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE) announced that the Company sought an extension of its previously announced stay of proceedings (“ Stay ”) under the Companies’ Creditors Arrangement Act (the “ ...
Antibe Therapeutics Inc. (“ Antibe ” or the “ Company ”) (TSX: ATE) announced that the Toronto Stock Exchange (“TSX”) is reviewing the eligibility for continued listing on the TSX of the securities of the Company. The TSX has identified the Compan...